Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Diseases

Free Subscription 12.01.2026 2 AJR Am J Roentgenol 3 Am J Gastroenterol 1 Biochem Biophys Res Commun 2 BMC Cancer 1 BMC Gastroenterol 1 Dig Dis Sci 1 Endoscopy 1 Eur Radiol 1 Gut 4 J Gastroenterol Hepatol 5 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. GABR A, Salem R
   Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma Definitive Therapy: Point-Simple, Reproducible, and Curative.
   AJR Am J Roentgenol. 2026 Jan 7. doi: 10.2214/AJR.25.34352.
   PubMed        
   
   
2. CIONI D, Lencioni R
   Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma Definitive Therapy: Counterpoint-Ablation Remains the Standard of Care.
   AJR Am J Roentgenol. 2026 Jan 7. doi: 10.2214/AJR.25.34301.
   PubMed        
   
   

   
   Am J Gastroenterol

3. XUE J, Zhang L, Xie N, Lei L, et al
   Primary hepatic somatostatinoma (G2) with diabetes and nodal metastasis: An exceptionally rare primary liver tumor.
   Am J Gastroenterol. 2026 Jan 9. doi: 10.14309/ajg.0000000000003908.
   PubMed        
   
   
4. SHROFF H, Shankar A, Baron A, Yoxheimer L, et al
   A Large Language Model Assistant for Summarizing Hepatology Referral Documents.
   Am J Gastroenterol. 2026 Jan 8. doi: 10.14309/ajg.0000000000003905.
   PubMed         Abstract available
   
   
5. PATIDAR KR, Hall L, Ogola GO, Pike F, et al
   Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock.
   Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003854.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

6. HUI H, Guzailiayi A, Sirui H, Danping L, et al
   Curcumin alleviates non-alcoholic fatty liver disease by modulating inflammation, barrier function, and gut microbiota.
   Biochem Biophys Res Commun. 2026;797:153146.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. SHEN X, Zhao D, Wang F, Li X, et al
   Dietary intervention reshapes gut microbiota and lipid metabolism to enhance anti-tumor immunity and prognosis in hepatocellular carcinoma: a randomized controlled trial.
   BMC Cancer. 2026;26:42.
   PubMed         Abstract available
   
   
8. CAI H, Hu G, Chen J, Feng H, et al
   The role of PLOD family genes in liver hepatocellular carcinoma: from mechanisms to therapeutic potential.
   BMC Cancer. 2026 Jan 5. doi: 10.1186/s12885-025-15472.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

9. ATASOY H, Levent A
   The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis.
   BMC Gastroenterol. 2026 Jan 7. doi: 10.1186/s12876-025-04516.
   PubMed        
   
   

   
   Dig Dis Sci

10. LAI SW, Chiu SC, Liao KF
    Lipid?Lowering Agents and Hepatocellular Carcinoma Risk.
    Dig Dis Sci. 2026 Jan 2. doi: 10.1007/s10620-025-09631.
    PubMed        
    
    

    
    Endoscopy

11. WATANABE M, Okuwaki K, Igarashi K, Adachi K, et al
    Rescue surgery for intra-abdominal migration of plastic stents in endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026;58.
    PubMed        
    
    

    
    Eur Radiol

12. ASMUNDO L, Mercaldo N, Furtado F, Herold A, et al
    A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosis.
    Eur Radiol. 2026 Jan 6. doi: 10.1007/s00330-025-12295.
    PubMed         Abstract available
    
    

    
    Gut

13. ZOU T, Wan J, Liao R, Bai L, et al
    Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD.
    Gut. 2026;75:382-397.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

14. LIU Z, Jiang H, Li F, Xie R, et al
    Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets.
    J Gastroenterol Hepatol. 2025 Dec 7. doi: 10.1111/jgh.70189.
    PubMed         Abstract available
    
    
15. LIM AH, Litwin PS, Dionela W, Tse E, et al
    Endoscopic Ultrasound Guided Portal Pressure Gradient Measurement in Predicting Outcomes of Abdominal Surgery in Patients With Chronic Liver Disease.
    J Gastroenterol Hepatol. 2026;41:286-292.
    PubMed         Abstract available
    
    
16. HUANG YC, Wang CW, Huang JC, Liang PC, et al
    FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.
    J Gastroenterol Hepatol. 2026;41:332-340.
    PubMed         Abstract available
    
    
17. AL-KHREISAT MJ, Kadhim-Abosaoda M, Abas Ibrahim N, Malathi H M, et al
    Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy.
    J Gastroenterol Hepatol. 2026 Jan 5. doi: 10.1111/jgh.70197.
    PubMed         Abstract available
    
    

    
    PLoS One

18. BAGULEY E, Knaub M, VanDyke J, Hirschfield G, et al
    Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study.
    PLoS One. 2026;21:e0340475.
    PubMed         Abstract available
    
    
19. CHIU YJ
    LIMPACAT: Multi-omics attention transformer for immune prediction in liver cancer using whole-slide imaging.
    PLoS One. 2026;21:e0339667.
    PubMed         Abstract available
    
    
20. NGUYEN TL, Tu TK, Phan TV, Nguyen CM, et al
    Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway.
    PLoS One. 2026;21:e0340868.
    PubMed         Abstract available
    
    
21. LIU XF, Wang KY, Shi HF, Li Y, et al
    The role of quantitative T1 and T2 mapping for detecting minimal hepatic encephalopathy in chronic hepatic schistosomiasis patients.
    PLoS One. 2026;21:e0339588.
    PubMed         Abstract available
    
    
22. PINJAROEN N, Pan-Ngum W, Poovorawan K, Wastlund D, et al
    Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis.
    PLoS One. 2026;21:e0337913.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. LI D, Loneker AE, Safraou Y, Ford J, et al
    Cholesterol-containing lipid crystals can directly stiffen the rat steatotic liver before fibrosis.
    Proc Natl Acad Sci U S A. 2026;123:e2518060123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.